These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 18262679)

  • 41. C-terminal LRRs of human Toll-like receptor 3 control receptor dimerization and signal transmission.
    Takada E; Okahira S; Sasai M; Funami K; Seya T; Matsumoto M
    Mol Immunol; 2007 Jul; 44(15):3633-40. PubMed ID: 17521732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The cytoplasmic 'linker region' in Toll-like receptor 3 controls receptor localization and signaling.
    Funami K; Matsumoto M; Oshiumi H; Akazawa T; Yamamoto A; Seya T
    Int Immunol; 2004 Aug; 16(8):1143-54. PubMed ID: 15226270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant.
    Hafner AM; Corthésy B; Merkle HP
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1386-99. PubMed ID: 23751781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of virus/double-stranded RNA-dependent induction of antimicrobial peptide hepcidin in trout macrophages.
    Chiou PP; Lin CM; Bols NC; Chen TT
    Dev Comp Immunol; 2007; 31(12):1297-309. PubMed ID: 17498800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toll-like receptor 3-initiated antiviral responses in mouse male germ cells in vitro.
    Wang T; Zhang X; Chen Q; Deng T; Zhang Y; Li N; Shang T; Chen Y; Han D
    Biol Reprod; 2012 Apr; 86(4):106. PubMed ID: 22262694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proinflammatory response of human leukemic cells to dsRNA transfection linked to activation of dendritic cells.
    Smits EL; Ponsaerts P; Van de Velde AL; Van Driessche A; Cools N; Lenjou M; Nijs G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    Leukemia; 2007 Aug; 21(8):1691-9. PubMed ID: 17525722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA.
    Schmidt KN; Leung B; Kwong M; Zarember KA; Satyal S; Navas TA; Wang F; Godowski PJ
    J Immunol; 2004 Jan; 172(1):138-43. PubMed ID: 14688319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TLR3 impairment in human newborns.
    Slavica L; Nordström I; Karlsson MN; Valadi H; Kacerovsky M; Jacobsson B; Eriksson K
    J Leukoc Biol; 2013 Nov; 94(5):1003-11. PubMed ID: 23901120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The dsRNA-mimetic poly (I:C) and IL-18 synergize for IFNgamma and TNFalpha expression.
    Balah A; Akool el-S; Bachmann M; Pfeilschifter J; Mühl H
    Biochem Biophys Res Commun; 2009 Nov; 389(4):628-33. PubMed ID: 19761760
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Analysis of the interaction between human TLR3 ectodomain and nucleic acids.
    Fukuda K; Tsujita T; Matsumoto M; Seya T; Sakiyama H; Nishikawa F; Nishikawa S; Hasegawa T
    Nucleic Acids Symp Ser (Oxf); 2006; (50):249-50. PubMed ID: 17150911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of toll-like receptors and their adaptors in adjuvant immunotherapy for cancer.
    Seya T; Akazawa T; Uehori J; Matsumoto M; Azuma I; Toyoshima K
    Anticancer Res; 2003; 23(6a):4369-76. PubMed ID: 14666723
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Direct effect of dsRNA mimetics on cancer cells induces endogenous IFN-β production capable of improving dendritic cell function.
    Gatti G; Nuñez NG; Nocera DA; Dejager L; Libert C; Giraudo C; Maccioni M
    Eur J Immunol; 2013 Jul; 43(7):1849-61. PubMed ID: 23636788
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel antagonist antibody to TLR3 blocks poly(I:C)-induced inflammation in vivo and in vitro.
    Bunting RA; Duffy KE; Lamb RJ; San Mateo LR; Smalley K; Raymond H; Liu X; Petley T; Fisher J; Beck H; Flavell RA; Alexopoulou L; Ward CK
    Cell Immunol; 2011; 267(1):9-16. PubMed ID: 21092943
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis.
    Wörnle M; Schmid H; Banas B; Merkle M; Henger A; Roeder M; Blattner S; Bock E; Kretzler M; Gröne HJ; Schlöndorff D
    Am J Pathol; 2006 Feb; 168(2):370-85. PubMed ID: 16436653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Targeting poly(I:C) to the TLR3-independent pathway boosts effector CD8 T cell differentiation through IFN-alpha/beta.
    Ngoi SM; Tovey MG; Vella AT
    J Immunol; 2008 Dec; 181(11):7670-80. PubMed ID: 19017955
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toll-like receptor 3 agonist enhances IFN-gamma and TNF-alpha production by murine uterine NK cells.
    Zhang J; Sun R; Wei H; Wu D; Tian Z
    Int Immunopharmacol; 2007 May; 7(5):588-96. PubMed ID: 17386406
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cytokine, chemokine, and adhesion molecule expression mediated by MAPKs in human corneal fibroblasts exposed to poly(I:C).
    Liu Y; Kimura K; Yanai R; Chikama T; Nishida T
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3336-44. PubMed ID: 18660424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of Toll-like receptor 3 as a potential therapeutic target in clear cell renal cell carcinoma.
    Morikawa T; Sugiyama A; Kume H; Ota S; Kashima T; Tomita K; Kitamura T; Kodama T; Fukayama M; Aburatani H
    Clin Cancer Res; 2007 Oct; 13(19):5703-9. PubMed ID: 17908959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TLR3 is essential for the induction of protective immunity against Punta Toro Virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not Poly(I:C): differential recognition of synthetic dsRNA molecules.
    Gowen BB; Wong MH; Jung KH; Sanders AB; Mitchell WM; Alexopoulou L; Flavell RA; Sidwell RW
    J Immunol; 2007 Apr; 178(8):5200-8. PubMed ID: 17404303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.